Lumenis® Signs Business Cooperation and Product Distribution Agreement With Dual-Laser, Developer of Valon® Scanning Photocoagulation Laser System

Share Article

“The cooperation with Dual Laser, is aligned with our corporate vision to offer smart, intuitive and cost-effective product solutions to our customers worldwide,” said Dov Ofer, President and CEO of Lumenis.

Lumenis® Ltd., one of the world's largest medical laser companies and a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for ophthalmic, aesthetic, and surgical applications, announced today that it has signed a business cooperation and product distribution agreement with Dual Laser Ltd. Oy. (“Dual Laser”), a privately-held company based in Finland, which developed and introduced a leading pattern scanning photocoagulation laser platform for retinal applications. The Valon product will be distributed by Lumenis in the United States, Japan and China (including SAR Hong Kong and Macau).

“The cooperation with Dual Laser is aligned with our corporate vision to offer smart, intuitive and cost-effective product solutions to our customers worldwide,” said Dov Ofer, President and CEO of Lumenis. “Furthermore, it is consistent with the strategic roadmap of the Vision Business Unit – one of our three core businesses – and our unique ability to leverage such innovative product solutions on a global scale.”

Multi-spot scanning laser photocoagulation is a technique that allows the delivery of various laser patterns onto the retina in pre-determined sequence, which meets specific clinical requirements, and significantly accelerates laser procedures such as pan-retinal photocoagulation (PRP). In addition, multi-spot laser technology causes less thermal damage to the neurosensory layers of the retina, thereby reducing the negative impact on the patient’s vision, and also meaningfully reduces patient discomfort during and following the procedure.

“The Valon® Scanning Photocoagulation Laser System is an excellent addition to the Lumenis Vision product portfolio,” said Kfir Azoulay who heads Lumenis Vision’s Global Marketing Organization. “Lumenis Vision is renowned for technological breakthroughs and a long list of industry gold-standards in the Retina field. Our company pioneered the first argon laser photocoagulator for ophthalmology and also developed and introduced the breakthrough multi-wavelength photocoagulation technology. With the signing of this agreement with Dual Laser, our customers in key markets around the world can now greatly benefit from state-of-the-art scanner technology, superior clinical performance and the market’s leading user-interface technology,” added Mr. Azoulay.

Dr. Pazit Pianka, a Senior Ophthalmologist and the Medical Director of Lumenis Vision, commented: “The Valon scanning photocoagulator has the most optimal and intuitive user interface I have worked with. In addition, all clinical performance parameters exceeded expectations when we ran comparative analyses of the Valon scanning capabilities with other scanning photocoagulators currently available in the market.”

“We are very excited to embark on this strategic alliance with Lumenis,” said Mr. Juha Viherkoski, President of Dual Laser. “Lumenis Vision is well-known in the ophthalmic laser industry for its global reach, customer support and strong brand name. This business cooperation will allow our team to continue developing outstanding ophthalmic laser products that significantly exceed customer expectations, while meaningfully increasing our global market reach.”

About Lumenis
Lumenis, one of the world's largest medical laser companies, is a global developer, manufacturer and distributor of laser and light-based devices for surgical, ophthalmic and aesthetic applications, with more than 800 employees worldwide. Lumenis has nearly 250 patents, over 75 FDA clearances, an installed base of over 80,000 systems and presence in over 100 countries. Lumenis endeavors to bring the finest state of the art technology products to the market, fulfilling the highest standards of excellence, quality and reliability, delivering premium value and service to its customers. The name Lumenis is derived from the Latin words meaning "Light of Life" highlighting the light which is the basis of our technologies used to enhance life. For more information about Lumenis and its products, please visit:

About Dual Laser Oy Ltd.
Dual Laser is a Helsinki (Vantaa)-based start-up company that developed and introduced a pattern scanning ophthalmic laser photocoagulator with market-unique user interface technology. The company was founded by Mr. Esa Viherkoski and Mr. Juha Viherkoski, medical laser veterans with over 30 years of collective experience in the field. The Valon product has been successfully introduced and installed in numerous countries around the world. The word Valon means “Light” in the Finnish language.

For further information contact:
Michelle Maydan
Director of Corporate Communications
e-mail: mmaydan(at)lumenis(dot)com
Lumenis®, and its logo are trademarks or registered trademarks of the Lumenis Group of Companies.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Maydan
Lumenis, LTD
Email >
Visit website